Improving the Recognition of GBS and CIDP in the Hospital Setting: Live Program

LIVE PROGRAM Designed for healthcare professionals. Earn AMA PRA Category 1 Credit™. Date: Tuesday, September 25, 2018 Time: 12:00 PM – 1:00 PM EST Join our experts for a one-hour, live webinar as they discuss how to manage patients with immune-mediated neuropathies such as GBS and CIDP. Learning Objectives Recognize signs and symptoms that may suggest…

Read More about Improving the Recognition of GBS and CIDP in the Hospital Setting: Live Program

Subcutaneous Immunoglobulin: A Newly Approved Treatment Option for CIDP

David Saperstein, MD Co-Director GBS/CIDP Center of Excellence Phoenix Neurological Associates Phoenix, AZ Intravenous immunoglobulin (IVIg) is one of the main therapies used to treat CIDP. This therapy can be very effective but there are drawbacks. Some people experience headaches related to the intravenous infusions. Some people have difficulty with IV access. Also, the need…

Read More about Subcutaneous Immunoglobulin: A Newly Approved Treatment Option for CIDP